4-(2-(4-(6-(2-(BENZYLAMINO)-2-OXOETHYL)PYRIDIN-3-YL)PHENOXY)ETHYL)MORPHOLINE 4-OXIDE
UNII L94HEZ3566
Substance Identification & Data
This profile provides standardized clinical and technical data for 4-(2-(4-(6-(2-(benzylamino)-2-oxoethyl)pyridin-3-yl)phenoxy)ethyl)morpholine 4-oxide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) L94HEZ3566.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C26H29N3O4 ZTYFJWPFHVQGTM-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4-(2-(4-(6-(2-(benzylamino)-2-oxoethyl)pyridin-3-yl)phenoxy)ethyl)morpholine 4-oxide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.